Kengreal Interactions
Showing entire list of all interactions, including brand names and combination drugs.
Go back to interactions summary
Medications known to interact with Kengreal
P
- Pamprin All Day Relief (naproxen)
- Panhematin (hemin)
- panobinostat
- paroxetine
- Paxil (paroxetine)
- Paxil CR (paroxetine)
- PediaCare Children's IB Ibuprofen Pain Reliever/Fever Reducer (ibuprofen)
- PediaCare Infants' IB Ibuprofen Pain Reliever/Fever Reducer (ibuprofen)
- pegaspargase
- Pennsaicin (capsaicin / diclofenac topical)
- Pennsaid (diclofenac topical)
- pentosan polysulfate sodium
- pentoxifylline
- Pentoxil (pentoxifylline)
- Persantine (dipyridamole)
- Persantine IV (dipyridamole)
- Pexeva (paroxetine)
- phenylbutazone
- Phyrago (dasatinib)
- piroxicam
- pirtobrutinib
- plasminogen, human
- Plavix (clopidogrel)
- Pletal (cilostazol)
- ponatinib
- Pondimin (fenfluramine)
- Ponstel (mefenamic acid)
- PosiFlush (heparin flush)
- Pradaxa (dabigatran)
- prasugrel
- Pred-Moxi-Nepaf (moxifloxacin / nepafenac / prednisolone ophthalmic)
- Prenatal DHA (omega-3 polyunsaturated fatty acids)
- Prevacid NapraPAC (lansoprazole / naproxen)
- Prevacid NapraPAC 375 (lansoprazole / naproxen)
- Prevacid NapraPAC 500 (lansoprazole / naproxen)
- Primrose Oil (evening primrose)
- Pristiq (desvenlafaxine)
- Proepa (omega-3 polyunsaturated fatty acids)
- Profenal (suprofen ophthalmic)
- ProFeno (fenoprofen)
- Profinac (diclofenac topical)
- Prolensa (bromfenac ophthalmic)
- Proprinal (ibuprofen)
- Prozac (fluoxetine)
- Prozac Weekly (fluoxetine)
More about Kengreal (cangrelor)
- Kengreal consumer information
- Check interactions
- Compare alternatives
- Pricing & coupons
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: platelet aggregation inhibitors
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.